OKUR vs AAPL: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

AAPL has stronger fundamentals based on our AI analysis.

OKUR
OnKure Therapeutics, Inc.
SELL
75%
Confidence
VS
AAPL
Apple Inc.
BUY
87%
Confidence

OKUR vs AAPL Fundamental Comparison

Metric OKUR AAPL
Revenue $3.4M $143.8B
Net Income $-59.5M $42.1B
Net Margin -1,733.7% 29.3%
ROE -105.9% 47.7%
ROA -95.8% 11.1%
Current Ratio 10.28x 0.97x
Debt/Equity 0.00x 1.00x
EPS $-4.40 $2.84

Green = Better metric | Red = Weaker metric

View Full OKUR Analysis →
View Full AAPL Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OKUR vs MSFT AAPL vs GOOGL OKUR vs AMZN AAPL vs NVDA

OKUR vs AAPL: Frequently Asked Questions

Is OKUR or AAPL a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. OKUR is rated SELL (75% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.

How does OKUR compare to AAPL fundamentally?

OnKure Therapeutics, Inc. has ROE of -105.9% vs Apple Inc.'s 47.7%. Net margins are -1,733.7% vs 29.3% respectively.

Which stock pays higher dividends, OKUR or AAPL?

OKUR has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OKUR or AAPL for long term?

For long-term investing, consider that OKUR has SELL rating with 75% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OKUR vs AAPL?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OKUR vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.